CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
Shirley, NY, 2024-Jan-08 — /EPR Network/ — CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its [read full press release…]